CRISPR Therapeutics shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 78 to 82.

A pair of horses recently towed an antique piece of farm equipment through a cornfield in Kresgeville. In their wake, columns of cornstalks fell to the ground, already bound together and tied with ...

This article is all about what’s new and what it might mean for us, covering the latest in genetics in news. New methods like ...

A study identified two key genes (CTNNA1 and BCL2L13) as suppressors in spread of colorectal cancer, revealing new strategies ...

External Affairs Minister S. Jaishankar on December 1 warned that the threat of biological weapons and bioterrorism is no ...

It might be time to look a bit off the beaten path, at names that can stand up to any AI-stock-led correction.

Five years ago this month, in November 2020, medical history was made at Richmond Pharmacology when a patient received the first CRISPR therapy delivered systemically through the bloodstream, using ...

In a major step forward for cancer care, researchers at ChristianaCare's Gene Editing Institute have shown that disabling the NRF2 gene with CRISPR technology can reverse chemotherapy resistance in ...

Scientists used CRISPR to disable the NRF2 gene, restoring chemotherapy sensitivity in lung cancer cells and slowing tumor growth. The technique worked even when only a fraction of tumor cells were ...